Chemical Compound Review:
SureCN8920 N-phenylquinazolin-4-amine
Synonyms:
Kinome_2867, CHEMBL289959, Enamine_003240, NSC-288013, Oprea1_243645, ...
Houghton,
Germain,
Harwood,
Schuetz,
Stewart,
Buchdunger,
Traxler,
Leggas,
Panetta,
Zhuang,
Schuetz,
Johnston,
Bai,
Sorrentino,
Zhou,
Houghton,
Stewart,
Lee,
Park,
Seo,
So,
Chung,
Yang,
Lee,
Park,
Lee,
Rocco,
Velho,
Marin,
de Arruda Rolim Filho,
Vercesi,
Rittner,
Franchini,
Hennequin,
Ballard,
Boyle,
Delouvrié,
Ellston,
Halsall,
Harris,
Hudson,
Kendrew,
Pease,
Ross,
Smith,
Vincent,
- Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro. Houghton, P.J., Germain, G.S., Harwood, F.C., Schuetz, J.D., Stewart, C.F., Buchdunger, E., Traxler, P. Cancer Res. (2004)
- Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis. Zhou, Y., Li, S., Hu, Y.P., Wang, J., Hauser, J., Conway, A.N., Vinci, M.A., Humphrey, L., Zborowska, E., Willson, J.K., Brattain, M.G. Cancer Res. (2006)
- Gefitinib modulates the function of multiple ATP-binding cassette transporters in vivo. Leggas, M., Panetta, J.C., Zhuang, Y., Schuetz, J.D., Johnston, B., Bai, F., Sorrentino, B., Zhou, S., Houghton, P.J., Stewart, C.F. Cancer Res. (2006)
- Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors. Blencke, S., Ullrich, A., Daub, H. J. Biol. Chem. (2003)
- Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase. Shewchuk, L., Hassell, A., Wisely, B., Rocque, W., Holmes, W., Veal, J., Kuyper, L.F. J. Med. Chem. (2000)
- Inhibition of growth of primary human tumour cell cultures by a 4-anilinoquinazoline inhibitor of the epidermal growth factor receptor family of tyrosine kinases. Baguley, B.C., Marshall, E.S., Holdaway, K.M., Rewcastle, G.W., Denny, W.A. Eur. J. Cancer (1998)
- 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Assefa, H., Kamath, S., Buolamwini, J.K. J. Comput. Aided Mol. Des. (2003)
- Novel 4-anilinoquinazolines with C-6 carbon-linked side chains: synthesis and structure-activity relationship of a series of potent, orally active, EGF receptor tyrosine kinase inhibitors. Hennequin, L.F., Ballard, P., Boyle, F.T., Delouvrié, B., Ellston, R.P., Halsall, C.T., Harris, C.S., Hudson, K., Kendrew, J., Pease, J.E., Ross, H.S., Smith, P., Vincent, J.L. Bioorg. Med. Chem. Lett. (2006)
- 1,4-dioxane-fused 4-anilinoquinazoline as inhibitors of epidermal growth factor receptor kinase. Lee, J.Y., Park, Y.K., Seo, S.H., So, I.S., Chung, H.K., Yang, B.S., Lee, S.J., Park, H., Lee, Y.S. Arch. Pharm. (Weinheim) (2001)
- Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41. Matheson, S.L., McNamee, J.P., Jean-Claude, B.J. Cancer Chemother. Pharmacol. (2003)
- The tyrosine kinase inhibitor PD153035: implication of labeling position on radiometabolites formed in vitro. Sam??n, E., Thorell, J.O., Fredriksson, A., Stone-Elander, S. Nucl. Med. Biol. (2006)
- High performance liquid chromatography analysis of a 4-anilinoquinazoline derivative (PD153035), a specific inhibitor of the epidermal growth factor receptor tyrosine kinase, in rat plasma. Rocco, S.A., Velho, J.A., Marin, R.M., de Arruda Rolim Filho, L., Vercesi, A.E., Rittner, R., Franchini, K.G. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2005)